1. Mining the role of RECQL5 in gastric cancer and seeking potential regulatory network by bioinformatics analysis
   Yijia Lin et al, 2020, Experimental and Molecular Pathology CrossRef
2. Ras-Mediated Activation of NF-κB and DNA Damage Response in Carcinogenesis
   Anas Ahmad et al, 2020, Cancer Investigation CrossRef
3. Design, Synthesis, and Evaluation of New Quinazolinone Derivatives that Inhibit Bloom Syndrome Protein (BLM) Helicase, Trigger DNA Damage at the Telomere Region, and Synergize with PARP Inhibitors
   Chen-Xi Wang et al, 2020, Journal of Medicinal Chemistry CrossRef
4. Involvement of Variants in the Genes Encoding BRCA1-Associated Genome Surveillance Complex (BASC) in the Development of Human Common Diseases
   N. P. Babushkina et al, 2021, Molecular Biology CrossRef
5. miR‑27b‑3p and miR‑607 cooperatively regulate BLM gene expression by directly targeting the 3'‑UTR in PC3 cells
   Yinglian Chen et al, 2019, Molecular Medicine Reports CrossRef
6. RecQ Helicase Somatic Alterations in Cancer
   Megha K. Thakkar et al, 2022, Frontiers in Molecular Biosciences CrossRef
7. Discovery of a Novel Bloom’s Syndrome Protein (BLM) Inhibitor Suppressing Growth and Metastasis of Prostate Cancer
   Xiao-Yan Ma et al, 2022, International Journal of Molecular Sciences CrossRef
8. Low expression of RecQ‑like helicase 5 is associated with poor prognosis in patients with gastric cancer
   Yijia Lin et al, 2019, Oncology Letters CrossRef
9. MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer
   Yike Li et al, 2022, Frontiers in Oncology CrossRef
10. Synthetic Lethal Interactions of RECQ Helicases
    Arindam Datta et al, 2021, Trends in Cancer CrossRef
11. Functions of BLM Helicase in Cells: Is It Acting Like a Double-Edged Sword?
    Ekjot Kaur et al, 2021, Frontiers in Genetics CrossRef
12. Design, synthesis and evaluation of N3-substituted quinazolinone derivatives as potential Bloom's Syndrome protein (BLM) helicase inhibitor for sensitization treatment of colorectal cancer
    Jia-Li Tu et al, 2023, European Journal of Medicinal Chemistry CrossRef
13. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
    Wen Xu et al, 2023, Open Medicine CrossRef
14. BLM promotes malignancy in PCa by inducing KRAS expression and RhoA suppression via its interaction with HDGF and activation of MAPK/ERK pathway
    Yingchu Guo et al, 2023, Journal of Cell Communication and Signaling CrossRef
15. The identification of six risk genes for ovarian cancer platinum response based on global network algorithm and verification analysis
    Linan Xing et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
16. A Pilot Study on the Whole Exome Sequencing of Prostate Cancer in the Indian Phenotype Reveals Distinct Polymorphisms
    Ayam Gupta et al, 2020, Frontiers in Genetics CrossRef
17. Discovery of Isaindigotone Derivatives as Novel Bloom’s Syndrome Protein (BLM) Helicase Inhibitors That Disrupt the BLM/DNA Interactions and Regulate the Homologous Recombination Repair
    Qi-Kun Yin et al, 2019, Journal of Medicinal Chemistry CrossRef
18. BLM can regulate cataract progression by influencing cell vitality and apoptosis
    Jing Xiang et al, 2019, Experimental Eye Research CrossRef
19. Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells
    Kun Chen et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
20. Large chromosomal deletions and impaired homologous recombination repairing in HEK293T cells exposed to polychlorinated biphenyl 153
    Jiaci Li et al, 2021, PeerJ CrossRef